SMI, Department of Health Science and Technology, School of Medicine, Aalborg University, Aalborg, Denmark.
Center for Neuroplasticity and Pain, Department of Health Science and Technology, School of Medicine, Aalborg University, Aalborg, Denmark.
Eur J Pain. 2019 Nov;23(10):1904-1912. doi: 10.1002/ejp.1465. Epub 2019 Aug 19.
Conditioned pain modulation (CPM) and offset analgesia are different features of descending pain inhibition. This study investigated CPM, offset analgesia and clinical pain measures in patients with knee osteoarthritis (KOA) before and after treatment with the combination of a non-steroidal anti-inflammatory drug (NSAIDs) plus acetaminophen.
Forty-two patients with KOA received Ibuprofen 1.2 g/daily and acetaminophen 3.0 g/daily for three weeks. Before administration, CPM magnitude was assessed as the difference between cuff pain detection (cPDT) with and without a conditioning stimulus (evoked by tourniquet pain). Offset analgesia was assessed as the pain intensities evoked by a constant 46°C for 30-s stimulus compared to an offset analgesia paradigm of 46°C for 5-s, 47°C for 5-s and 46°C for 20-s. The worst pain within the last 24-hr and pain during activity were assessed before and after treatment.
Clinical pain significantly decreased after treatment (p < 0.001) and less efficient CPM before treatment was associated with weaker analgesic effect (R = 0.354, p = 0.043). No significant modulation of CPM or offset analgesia was found for the treatment.
This study found that less efficient CPM is associated with reduced analgesic effect of NSAIDs plus acetaminophen in patients with KOA whereas the treatment did not modulate CPM nor offset analgesia magnitude.
This study demonstrated that conditioned pain modulation is correlated with the response to a standard pharmaceutical interventions treating osteoarthritis pain. Furthermore, we demonstrated that a decrease in clinical pain intensity is not associated with a normalization of conditioned pain modulation or offset analgesia, which questions if restoring these descending pain inhibitory mechanisms are pain intensity driven.
条件性疼痛调制(CPM)和偏移镇痛是下行性疼痛抑制的不同特征。本研究调查了膝骨关节炎(KOA)患者在接受非甾体抗炎药(NSAIDs)加醋氨酚联合治疗前后的 CPM、偏移镇痛和临床疼痛测量。
42 例 KOA 患者每天接受布洛芬 1.2 g 和醋氨酚 3.0 g 治疗三周。在给药前,通过测量有和没有条件刺激(由止血带疼痛引起)时的袖带疼痛检测(cPDT)来评估 CPM 幅度。偏移镇痛通过比较 30 秒 46°C 恒定刺激与 5 秒 46°C、5 秒 47°C 和 20 秒 46°C 的偏移镇痛范式来评估。治疗前后评估过去 24 小时内的最痛和活动时的疼痛。
治疗后临床疼痛显著减轻(p<0.001),治疗前 CPM 效率较低与镇痛效果较弱相关(R=0.354,p=0.043)。治疗未发现 CPM 或偏移镇痛有明显调节。
本研究发现,KOA 患者 CPM 效率较低与 NSAIDs 加醋氨酚的镇痛效果降低有关,而治疗并未调节 CPM 或偏移镇痛幅度。
本研究表明,条件性疼痛调制与标准药物干预治疗骨关节炎疼痛的反应相关。此外,我们还证明临床疼痛强度的降低与条件性疼痛调制或偏移镇痛的正常化无关,这表明恢复这些下行性疼痛抑制机制是否与疼痛强度有关。